医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Indian Peripheral Cardiovascular Device Market Analyzed and Forecast in New iData Research Report Now Available at MarketPublishers.com

2012年11月29日 PM06:55
このエントリーをはてなブックマークに追加


 

LONDON

The market for peripheral vascular devices registered considerable growth in 2011 in India. Its size increased by one fifth if compared to 2010. Besides, the local market is set to grow further at CAGR of 20 percent or even more up to 2019. Divided into a raft of sectors, the market comprises embolic protection devices, stents, surgical grafts, introducer sheaths and a lot more.

Both domestic and overseas companies are active in the Indian peripheral vascular device market. Terumo, Boston Scientific, Abbott Laboratories and C. R. Bard are amid top market players.

New market research report “Indian Peripheral Vascular Device Market” drawn up by iData Research is a valuable source of knowledge for peripheral vascular device companies, researchers, medical equipment traders as well as buyers and individuals interested in trends of the peripheral vascular device market in India. The study examines and assesses a current state of the Indian market (existing and potential markets are included). Valuable data on selling prices and technologies, discussion of market opportunities and threats, drivers and restraints can be found in the report. Detailed profiles of major market participants, overview of market segments and future outlook are also offered in the report.

Report Details:

Title: Indian Peripheral Vascular Device Market

Published: December, 2012

Pages: 194

Price: US$ 6,995.00

http://marketpublishers.com/report/medical_devices/cardiovascular_devices/indian-peripheral-vascular-device-market.html

More Research Reports on Medical Markets by iData Research are Available:

More new market research reports by iData Research can be found at http://marketpublishers.com/members/idata_research/info.html

CONTACT

The Market Publishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax:
+44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the Trial of APR003, an Orally-Administered Gastrointestinal/Liver-Targeted TLR7 Agonist for Treatment of Advanced Colorectal Cancer (CRC) with Malignant Liver Lesions
  • Taiwan Innotech Expo (TIE) Showcases Strong Ecosystems in the Post-Pandemic World
  • Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market
  • GC Pharma Taps Small Molecule AI Expert Atomwise to Expand Hemophilia Franchise
  • 随着越来越多的客户和合作伙伴使用Denodo冠状病毒数据门户计划来对抗和最小化COVID-19的影响,其采纳率在不断提高